Galmed Pharmaceuticals Ltd
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. It has a research agreement with Gannex Pharma Co., Ltd. to develop a combination therapy of ASC41 (THR-beta agonist) and Aramchol (SCD 1 inhibitor) for the treatment of NASH; a research and development collaboration agreement with MyBiotics Pharma Ltd. to identify the selected microbiome repertoire associated with the response to Aramchol; and a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Tel Aviv, Israel. Show More...
-
Website https://www.galmedpharma.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 1.43 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.62 -1.64 -0.88 -0.96 -1.49 -0.98 -0.54 -0.97 -1.09 Dividends USD Payout Ratio % * Shares Mil 5.0 11.0 10.0 11.0 11.0 12.0 18.0 21.0 21.0 Book Value Per Share * USD 3.0 2.26 1.28 0.45 4.32 3.66 3.03 Free Cash Flow Per Share * USD -0.39 -0.88 -1.04 -1.01 -0.58 -0.62 Return on Assets % -413.25 -55.02 -37.15 -83.28 -68.15 -17.88 -24.4 -29.1 Financial Leverage (Average) 1.05 1.13 1.49 1.24 1.03 1.1 1.1 Return on Equity % -61.81 -40.12 -103.94 -91.54 -19.01 -25.94 -30.91 Return on Invested Capital % -62.01 -41.07 -104.1 -92.03 -20.44 -28.29 -33.15 Interest Coverage Current Ratio 1.43 0.09 28.76 9.2 3.44 4.98 33.41 11.02 11.57 Quick Ratio 1.42 0.09 28.67 9.09 3.38 4.95 33.35 10.92 11.55 Debt/Equity 0.010